Novel multi-layer APPPA microcapsules for oral delivery: Preparation condition, stability and permeability

Indian Journal of Biochemistry and Biophysics

Volumn 46, Issue 6, 2009, Pages 491-497

  Ouyang, Wei ^a   Chen, Hongmei ^a   Jones, Mitchell L ^a   Haque, Tasima ^a   Martoni, Christopher ^a   Afkhami, Fateme ^a   Prakash, Satya ^a  

^a Department of Biomedical Engineering and Physiology   (Canada)

Author keywords

APPPA; Artificial cells; GI stability; Membrane strength; Microcapsule; Oral delivery; Pectin

Indexed keywords

ALGINIC ACID; APPPA COMPOUND; CALCIUM CHLORIDE; PECTIN; SODIUM; SODIUM CHLORIDE; MICROCAPSULE;

ANIMAL; ARTICLE; CATTLE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG FORMULATION; DRUG STABILITY; GASTROINTESTINAL TRACT; METABOLISM; METHODOLOGY; MICROCAPSULE; ORAL DRUG ADMINISTRATION; BOVINAE; PROCEDURES;

ADMINISTRATION, ORAL; ALGINATES; ANIMALS; CALCIUM CHLORIDE; CAPSULES; CATTLE; CELL MEMBRANE PERMEABILITY; DRUG COMPOUNDING; DRUG STABILITY; GASTROINTESTINAL TRACT; PECTINS; SODIUM; SODIUM CHLORIDE;

BACTERIA (MICROORGANISMS);

EID: 77954339418     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prokop A, Hunkeler D, DiMari S, Haralson M A & Wang T G (1998) Water soluble polymers for immunoisolation I, Complex coacervation and cytotoxicity. Microencapsulation - Microgels - Iniferters 136, 1-51
2. Prokop A, Hunkeler D, Powers A C, Whitesell R R & Wang T G (1998) Water soluble polymers for immunoisolation II, Evaluation of multicomponent microencapsulation systems. Microencapsulation - Microgels - Iniferters 136, 53-73
3. Soon-Shiong P (1999) Treatment of type I diabetes using encapsulated islets. Adv Drug Delivery Rev 35, 259-270
4. Soonshiong P, Lu Z N, Grewal I, Lanza R P & Clark W (1990) An In vitro Method of Assessing the Immunoprotective Properties of Microcapsule Membranes Using Pancreatic and Tumor-Cell Targets. Transplant Proc 22, 754-755
5. Chang T M S & Prakash S (2001) Microencapsulated genetically engineered microorganisms for clinical application. US Patent 6217859
6. Prakash S & Chang T M (1996) Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nat Med 2, 883-887 (Pubitemid 26296758)
7. Reuter G (2001) Probiotics - Possibilities and limitations of their application in food, animal feed, and in pharmaceutical preparations for man and animals. Berliner Munchener Tierarztliche Wochenschrift 114, 410-419
8. Reuter G (2001) The Lactobacillus and Bifidobacterium microflora of the human intestine, composition and succession. Curr Iss Intest Microbiol 2, 43-53
9. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W & Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355
10. Audet P, Paquin C & Lacroix (1991) Effect of Medium and Temperature of Storage on Viability of Lactic-Acid Bacteria Immobilized in Kappa-Carrageenan-Locust Bean Gum Gel Beads. Biotechnol Tech 5, 307-312
11. Audet P, Paquin C & Lacroix C (1988) Immobilized Growing Lactic-Acid Bacteria with K-Carrageenan - Locust Bean Gum Gel. Appl Microbiol Biotechnol 29, 11-18
12. Audet P, Paquin C & Lacroix C (1990) Batch Fermentations with A Mixed Culture of Lactic-Acid Bacteria Immobilized Separately in Kappa-Carrageenan Locust Bean Gum Gel Beads. Appl Microbiol Biotechnol 32, 662-668
13. Weisz R R (1980) Hypokalemia-Induced Clinical Neurophysiological Changes in the Human Neuromuscular-Junction. Clin Res 28, A752
14. Norton S, Lacroix C & Vuillemard J C (1993) Effect of Ph on the Morphology of Lactobacillus-Helveticus in Free-Cell Batch and Immobilized-Cell Continuous Fermentation. Food Biotechnol 7, 235-251
15. Sun A M, Cai Z, Shi Z, Ma F & Oshea G M (1987) Microencapsulated Hepatocytes - An In vitro and In vivo Study. Biomater Artif Cells Artif Organs 15, 483-496
16. Prakash S & Chang T M S (1998) Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E-coli DH5 cells for urea removal. Artif Cells Blood Substitutes Immobilization Biotechnol 26, 35-51
17. Sun A M, Oshea G M & Goosen M F A (1984) Injectable Microencapsulated Islet Cells As A Bioartificial Pancreas. Appl Biochem Biotechnol 10, 87-99
18. Lanza R P, Kuhtreiber W M, Ecker D, Staruk J E & Chick W L (1995) Xenotransplantation of Porcine and Bovine Islets Without Immunosuppression Using Uncoated Alginate Microspheres. Transplantation 59, 1377-1384
19. Liu P & Krishnan T R (1999) Alginate-pectin-poly-L-lysine particulate as a potential controlled release formulation. J Pharm Pharmacol 51, 141-149
20. King A, Sandler S & Andersson A (2001) The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res 57, 374-383
21. Ouyang W, Chen H, Metz T, Jones M L & Prakash S (2002) Novel artificial cell formulation, design, preparation and morphology studies. Polymers in Medicine and Biology. Abstract in American Chemical Society Symposia, California
22. Vandamme T F, Lenourry A, Charrueau C & Chaumeil J (2002) The use of polysaccharides to target drugs to the colon. Carbohydr Polym 48, 219-231
23. Sefton M V, May M H, Lahooti S & Babensee J E (2000) Making microencapsulation work, conformal coating, immobilization gels and in vivo performance. J Controlled Release 65, 173-186
24. Ouyang, W, Chen H, Jones M L, Metz T, Haque T, Martoni C & Prakash S (2004) Artificial cell microcapsule for oral delivery of live bacterial cells for therapy, design, preparation, and in-vitro characterization. J Pharm Pharm Sci 7, 315-324
25. Gugerli R, Cantana E, Heinzen C, von Stockar U & Marison I W (2002) Quantitative study of the production and properties of alginate/poly-L-lysine microcapsules. J Microencapsulation 19, 571-590